SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Canadian Government Could Face Class Action Lawsuit Over Cannabis Legalisation 

    By

    The Canadian Federal government’s failure to facilitate research into the potential health issues associated with cannabis consumption.

    According to Toronto-based newspaper The Globe and Mail, the former Canadian Health Minister has said the lack of research following recreational cannabis legalisation in 2018 was a ‘big disappointment’.

    “The big disappointment coming out of the legalisation project is that governments and researchers have not stepped up in the way that we had hoped after legalisation to do a lot of that research,” Anne McLellan, who was part of the task force responsible for laying the groundwork for legalisation said.

    READ MORE: First Month of Maryland Cannabis Sales Reach Over $80 million

    She continued that she had hoped the government would incentivise private sector parties to conduct research into the effects of cannabis consumption which had been largely restricted during prohibition.

    With the last study into cannabis sales and consumption published by Health Canada in 2013, Ms McLellan argued that the government could ‘potentially’ face a class action lawsuit.

    Despite this, she stipulated that any such lawsuit could yet be years away, so ample time is available for the government to rectify the situation.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free